Reports Q4 revenue $1.46B, consensus $1.46B. John Rademacher, Chief Executive Officer, commented, “Our team continued to execute at a very high level to deliver extraordinary care and solid results in the fourth quarter and full year of 2025. During 2025, we served over 315,000 patients and they remain at the center of everything we do. We continued to make significant progress against our key priorities to build a sustainable growth enterprise while navigating a dynamic industry environment. As we look ahead in 2026, I am excited about the opportunities to further our mission and capitalize on the positive long-term growth trends across our industry and the strength of our position to serve more patients.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- OPCH Upcoming Earnings Report: What to Expect?
- Option Care Health price target raised to $37 from $27 at TD Cowen
- Option Care Health price target raised to $42 from $38 at Barrington
- Option Care Health: Resilient Core Growth, Structural Tailwinds, and Capital Allocation Support Buy Rating
- Option Care Health price target raised to $38 from $36 at Citizens
